Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Bratisl Lek Listy ; 118(3): 137-141, 2017.
Article in English | MEDLINE | ID: mdl-28319407

ABSTRACT

AIM: This study was planned to evaluate blood and tissue levels of procalcitonin, IL-6 and Oxidative Stress Index (OSI), which have a role in the pathophysiology of inflammation, in rats with experimental mild and severe pancreatitis. MATERIAL AND METHODS: Thirty male Wistar Albino rats were included in the study and the rats were equally divided into the three groups. After 1, 5 and 24 hours, blood was obtained from the tail of all rats and samples were taken from pancreas tissue after 24 hours. Amylase, lipase, AST, ALT, WBC, LDH, glucose, total bilirubin, direct bilirubin, GGT, ALP and TNF-α, Procalcitonin and IL-6 levels were evaluated from blood and tissue specimens. RESULTS: The mild pancreatitis group (group 1) and the severe pancreatitis group (group 3) were compared according to the OSI, Amylase, Lipase, Pct, IL-6, AST, ALT, Glucose, WBC, LDH and Tnf-α levels. In the severe pancreatitis group, a statistically significant increase was detected compared to the mild pancreatitis group (p < 0.05). There was no statistically significant difference in TOS, T.Bil, D.Bil, GGT and ALP values (p > 0.05). Statistically significant increase was observed in severe pancreatitis group according to OSI, Amylase, Lipase, Pct, IL-6, LDH, WBC and TNF-α levels samples obtained from pancreatic tissues, compared to mild pancreatitis group (p < 0.05). CONCLUSION: In conclusion, our study showed that OSI, TNF-α, IL-6 and procalcitonin levels increases proportionally with the severity of pancreatitis. This also suggests that OSI, TNF-α, IL-6 and procalcitonin are the guiding substances in acute pancreatitis, and that this damage increases as the duration and severity of the pathological process increase. However, this result must be confirmed with more detailed and broadly planned future studies (Fig. 3, Ref. 25).


Subject(s)
Calcitonin/metabolism , Interleukin-6/metabolism , Oxidative Stress , Pancreas/metabolism , Pancreatitis/metabolism , Acute Disease , Alanine Transaminase/metabolism , Alkaline Phosphatase/metabolism , Amylases/metabolism , Animals , Aspartate Aminotransferases/metabolism , Bilirubin/metabolism , Blood Glucose/metabolism , L-Lactate Dehydrogenase/metabolism , Lipase/metabolism , Male , Rats , Rats, Wistar , Severity of Illness Index , Tumor Necrosis Factor-alpha/metabolism , gamma-Glutamyltransferase/metabolism
2.
Eur Rev Med Pharmacol Sci ; 20(10): 2168-73, 2016 05.
Article in English | MEDLINE | ID: mdl-27249620

ABSTRACT

OBJECTIVE: In this study, we investigated whether the administration of calcium dobesilate (CD) affects oxidative stress markers and histopathological outcomes in a rat model of intestinal ischemia-reperfusion (IR) injury. MATERIALS AND METHODS: This study was conducted with 30 male Wistar rats. The rats were randomly assigned to three groups as follows: a sham group (n = 10), an IR group (n = 10), and an IR + CD group (n = 10). In the sham group, superior mesenteric artery (SMA) dissection alone was performed during laparotomy. In the IR group, the procedure included SMA occlusion for 60 min, followed by reperfusion for 60 min. In the IR + CD group, CD (100 mg/kg/day) was additionally given for two days before laparotomy by intragastric lavage. In all the rats, 2 ml of blood were drawn, and an ileal segment (approximately 2 cm in size) was removed to evaluate oxidative stress markers. The ileal segment removed was divided into two pieces, and one piece was reserved for histopathological evaluation. RESULTS: Compared to the other groups, both serum and tissue oxidative stress indices were lower in the IR + CD group. The decrease was due to CD increasing the total antioxidant capacity. Moreover, the histological analysis showed that CD reduced tissue injury. CONCLUSIONS: CD may exert a protective effect against intestinal IR injury by increasing antioxidant capacity.


Subject(s)
Calcium Dobesilate/pharmacology , Hemostatics/pharmacology , Intestines/blood supply , Oxidative Stress/drug effects , Reperfusion Injury/prevention & control , Animals , Antioxidants/metabolism , Calcium Dobesilate/administration & dosage , Hemostatics/administration & dosage , Intestinal Mucosa/metabolism , Male , Rats , Rats, Wistar , Reperfusion Injury/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL